Robertet (ENXTPA:RBT) Could Be 20% Below Fair Value After Its H1 Revenue Update

Robertet revenue update and what it could mean for investors

Robertet (ENXTPA:RBT) reported unaudited first half 2026 revenue of €444.281 million, slightly below the €446.337 million posted a year earlier. Management highlighted euro appreciation and consolidation scope changes as key headwinds.

See our latest analysis for Robertet.

At a share price of €802.0, Robertet has seen its short term momentum soften, with a 7 day share price return down 2.43% and year to date share price return down 8.76%, while the 5 year total shareholder return is down 15.91%.

If this earnings update has you reassessing your watchlist, it can help to widen the lens and look at 104 top founder-led companies

The recent slip in Robertet’s share price comes after revenue that is broadly flat once currency and scope effects are considered. Is this mainly a reset in sentiment, or a sign the market now questions the core business valuation?

Price-to-earnings of 17.2x for Robertet: Is it justified?

On the current numbers, Robertet trades on a P/E of 17.2x, which screens as slightly expensive relative to its own estimated fair P/E of 16.3x, yet still below peers and the wider European Chemicals industry.

The P/E multiple compares the company’s share price with its earnings per share. For a business like Robertet that is profitable with what appear to be high quality earnings and a track record of profit growth, investors often watch this measure to gauge how much the market is willing to pay for each unit of current earnings.

Here, Robertet looks a little rich versus the estimated fair P/E level. This suggests the valuation could be ahead of that fair ratio that the market could move toward over time. However, the same 17.2x P/E looks cheaper when set against the European Chemicals industry average of 19.7x and an even higher peer group average of 27.1x. This implies investors are paying less for Robertet’s earnings than for many sector peers.

Explore the SWS fair ratio for Robertet

Result: Price-to-earnings of 17.2x (ABOUT RIGHT)

However, investors in Robertet still need to watch for any sustained pressure on revenue growth and earnings quality, as this could challenge the current P/E premium.

Find out about the key risks to this Robertet narrative.

Another view on Robertet using the SWS DCF model

While the 17.2x P/E makes Robertet look only slightly expensive versus its fair ratio of 16.3x, the SWS DCF model points the other way. On this view, the stock at €802 trades about 19.5% below an estimated cash flow value of €996.79, which suggests a potential valuation gap to weigh carefully.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Robertet for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 253 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Does this mixed picture on Robertet leave you curious rather than convinced? Move quickly to review the data yourself, then weigh it against the 3 key rewards

Looking for more investment ideas beyond Robertet?

If Robertet has sharpened your focus, do not stop here. Broadening your watchlist with fresh ideas can help you compare quality, risk, and value more confidently.

• Spot potential value opportunities early and review 253 high quality undervalued stocks that combine appealing pricing with solid underlying businesses.
• Strengthen your focus on financial resilience and scan the solid balance sheet and fundamentals stocks screener (414 results) for companies that may better handle tough conditions.
• Unearth off-the-radar opportunities before others and work through the screener containing 544 high quality undiscovered gems with strong fundamentals that might not yet be widely followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com